In contrast, GSH-low cells (HCC70 and MDA-MB-436) and a HER2-amplified basal breast cancer cell line (HCC1954) showed substantial antagonism (Supplementary Fig. 3f–h), likely due to their limited dependency on the GSH pathway. The gene discussed is ERBB2; the disease is breast cancer.